| DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma NC Sheffield, G Pierron, J Klughammer, P Datlinger, A Schönegger, ... Nature medicine 23 (3), 386-395, 2017 | 223 | 2017 |
| Bone microenvironment signals in osteosarcoma development. RR Alfranca , Martinez-Cruzado L, Tornin J, Abarrategi A, Amaral T, de Alava ... Cell Mol Life Sci., 2015 | 195 | 2015 |
| Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target D Herrero-Martin, D Osuna, JL Ordonez, V Sevillano, AS Martins, ... British journal of cancer 101 (1), 80-90, 2009 | 139 | 2009 |
| The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin JL Ordóñez, AT Amaral, AM Carcaboso, D Herrero-Martín, ... Oncotarget 6 (22), 18875, 2015 | 85 | 2015 |
| IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis AS Martins, JL Ordóñez, AT Amaral, F Prins, G Floris, M Debiec-Rychter, ... PloS one 6 (5), e19846, 2011 | 63 | 2011 |
| The clinical relevance of molecular genetics in soft tissue sarcomas JL Ordóñez, D Osuna, DJ García-Domínguez, AT Amaral, AP Otero-Motta, ... Advances in Anatomic Pathology 17 (3), 162-181, 2010 | 48 | 2010 |
| Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents AT Amaral, C Garofalo, R Frapolli, MC Manara, C Mancarella, S Uboldi, ... Clinical Cancer Research 21 (6), 1373-1382, 2015 | 44 | 2015 |
| Selective modulation by PARP-1 of HIF-1α-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions JM Martí, A Garcia-Diaz, D Delgado-Bellido, F O'Valle, A González-Flores, ... Redox Biology 41, 101885, 2021 | 42 | 2021 |
| Ex vivo identification and characterization of a population of CD13high CD105+ CD45− mesenchymal stem cells in human bone marrow C Muñiz, C Teodosio, A Mayado, AT Amaral, S Matarraz, P Bárcena, ... Stem Cell Research & Therapy 6, 1-12, 2015 | 41 | 2015 |
| Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications AT Amaral, MC Manara, D Berghuis, JL Ordóñez, M Biscuola, ... PloS one 9 (2), e85814, 2014 | 40 | 2014 |
| Preclinical efficacy of endoglin-targeting antibody–drug conjugates for the treatment of Ewing sarcoma P Puerto-Camacho, AT Amaral, SE Lamhamedi-Cherradi, BA Menegaz, ... Clinical Cancer Research 25 (7), 2228-2240, 2019 | 33 | 2019 |
| Endoglin in the spotlight to treat cancer T González Muñoz, AT Amaral, P Puerto-Camacho, H Peinado, ... International Journal of Molecular Sciences 22 (6), 3186, 2021 | 22 | 2021 |
| Hippo pathway effectors YAP1/TAZ induce an EWS–FLI1‐opposing gene signature and associate with disease progression in Ewing sarcoma P Rodríguez‐Núñez, L Romero‐Pérez, AT Amaral, P Puerto‐Camacho, ... The Journal of Pathology 250 (4), 374-386, 2020 | 22 | 2020 |
| Innovative therapies in Ewing sarcoma AT Amaral, JL Ordóñez, AP Otero-Motta, DJ García-Domínguez, ... Advances in Anatomic Pathology 21 (1), 44-62, 2014 | 19 | 2014 |
| VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry D Delgado-Bellido, E Zamudio-Martínez, M Fernández-Cortés, ... Cell Death & Disease 14 (2), 135, 2023 | 10 | 2023 |
| Breakthrough technologies reshape the Ewing sarcoma molecular landscape C Salguero-Aranda, AT Amaral, J Olmedo-Pelayo, J Diaz-Martin, E Álava Cells 9 (4), 804, 2020 | 10 | 2020 |
| Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell–Matrix Interactions P Puerto-Camacho, J Díaz-Martín, J Olmedo-Pelayo, A Bolado-Carrancio, ... International Journal of Molecular Sciences 23 (15), 8657, 2022 | 6 | 2022 |
| Genetic alterations and deregulation of hippo pathway as a pathogenetic mechanism in bone and soft tissue sarcoma C Salguero-Aranda, J Olmedo-Pelayo, E de Álava, AT Amaral, ... Cancers 14 (24), 6211, 2022 | 2 | 2022 |
| Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin JL Ordóñez, AT Amaral, AM Carcaboso, D Herrero-Martín, ... Oncotarget 8 (26), 43592, 2017 | 1 | 2017 |
| VE-Cadherin modulates ß-catenin/TCF-4 to enhance Vasculogenic Mimicry D Delgado-Bellido, E Zamudio-Martínez, M Fernández-Cortés, ... NATURE PUBLISHING GROUP, 2023 | | 2023 |
ENRIQUE DE ÁLAVAInstituto de Biomedicina de Sevilla (Hospital Universitario Virgen del Rocío/Universidad de SevillaVerified email at us.es
